US7785631B2 - Solid dose delivery vehicle and methods of making same - Google Patents

Solid dose delivery vehicle and methods of making same Download PDF

Info

Publication number
US7785631B2
US7785631B2 US11/134,700 US13470005A US7785631B2 US 7785631 B2 US7785631 B2 US 7785631B2 US 13470005 A US13470005 A US 13470005A US 7785631 B2 US7785631 B2 US 7785631B2
Authority
US
United States
Prior art keywords
therapeutic
therapeutic composition
particles
bioactive
glass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US11/134,700
Other versions
US20050276846A1 (en
Inventor
Bruce J. Roser
Jaap Kampinga
Camilo Colaco
Julian Blair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Quadrant Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US08/349,029 priority Critical patent/US6290991B1/en
Priority to US09/628,380 priority patent/US6331310B1/en
Priority to US09/945,180 priority patent/US6565871B2/en
Priority to US10/376,136 priority patent/US6893657B2/en
Priority to US10/652,212 priority patent/US7056495B2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23370596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US7785631(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Drug Delivery Ltd filed Critical Quadrant Drug Delivery Ltd
Priority to US11/134,700 priority patent/US7785631B2/en
Publication of US20050276846A1 publication Critical patent/US20050276846A1/en
Assigned to QUADRANT HEALTHCARE (UK) LIMITED reassignment QUADRANT HEALTHCARE (UK) LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: QUADRANT HOLDINGS CAMBRIDGE LIMITED
Assigned to QUADRANT DRUG DELIVERY LIMITED reassignment QUADRANT DRUG DELIVERY LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ELAN DRUG DELIVERY LIMITED
Assigned to QUADRANT HOLDINGS CAMBRIDGE LIMITED reassignment QUADRANT HOLDINGS CAMBRIDGE LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BLAIR, JULIAN, KAMPINGA, JAAP, ROSER, BRUCE J., COLACO, CAMILO
Assigned to ELAN DRUG DELIVERY LIMITED reassignment ELAN DRUG DELIVERY LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: QUADRANT HEALTHCARE (UK) LIMITED
Publication of US7785631B2 publication Critical patent/US7785631B2/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links